XRN
ACHAT TOTAL: 28 925 titres (~1 049 601,00 $ US)
- Insiders
- Decker Mark Okey Jr, Roseth Aaron Robert
- Total bought
- $1,049,601
- Total sold
- —
- Last activity
- 2026-08-12
- Last synced
-
2026-08-21 23:36:53
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-09-06
Despite a meaningful insider cluster buy signal (score 72, confidence 0.68) suggesting insider conviction around the senior housing pivot, the underlying financial health is critically compromised with liquidity scores…
The first sentence of the analysis written for XRN on 2026-09-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 6.4% | 78.9% | 80.1% | 81.6% | 86.6% | |
| Ebit Margin | 23.4% | 25.6% | 37.3% | 33.0% | 32.8% | |
| Ebitda Margin | 60.1% | 66.1% | 79.2% | 75.0% | 73.7% | |
| Operating Profit Margin | 30.7% | 23.6% | 26.9% | 28.2% | 31.9% | |
| Pretax Profit Margin | -4.3% | 4.8% | 15.4% | 14.6% | 15.8% | |
| Continuous Operations Profit Margin | -4.3% | 4.8% | 15.4% | 14.6% | 15.8% | |
| Net Profit Margin | -3.6% | 4.8% | 14.6% | 14.0% | 15.2% | |
| Bottom Line Profit Margin | -3.6% | 0.6% | 10.5% | 9.7% | 10.2% | |
| Current Ratio | 0.000 | 0.026 | 0.023 | 0.046 | 0.046 | |
| Quick Ratio | 0.000 | 0.026 | 0.023 | 0.046 | 0.046 | |
| Solvency Ratio | 0.075 | 0.090 | 0.120 | 0.103 | 0.104 | |
| Cash Ratio | 0.000 | 0.010 | 0.002 | 0.006 | 0.013 | |
| Price To Earnings Ratio | -38.418 | 112.774 | 6.080 | 34.275 | 36.041 | |
| Price To Earnings Growth Ratio | 0.098 | -1.192 | 0.013 | 6.649 | -0.332 | |
| Forward Price To Earnings Growth Ratio | 0.098 | -1.192 | 0.013 | 6.649 | -0.332 | |
| Price To Earnings Diluted Ratio | -38.418 | 112.774 | 6.080 | 34.275 | 7.193 | |
| Price To Earnings Diluted Growth Ratio | 0.098 | -1.192 | 0.013 | -0.434 | -0.050 | |
| Price To Book Ratio | 0.918 | 0.173 | 0.157 | 0.145 | 0.136 | |
| Price To Sales Ratio | 2.905 | 0.666 | 0.650 | 0.667 | 0.732 | |
| Price To Free Cash Flow Ratio | -57.895 | -3.677 | 1.570 | -1.149 | -0.639 | |
| Price To Operating Cash Flow Ratio | 6.354 | 1.316 | 1.339 | 1.196 | 1.230 | |
| Debt To Assets Ratio | 0.534 | 0.520 | 0.492 | 0.506 | 0.459 | |
| Debt To Equity Ratio | 1.302 | 1.224 | 1.070 | 1.113 | 0.931 | |
| Debt To Capital Ratio | 0.566 | 0.550 | 0.517 | 0.527 | 0.482 | |
| Long Term Debt To Capital Ratio | 0.564 | 0.026 | 0.042 | 0.084 | 0.084 | |
| Financial Leverage Ratio | 2.437 | 2.352 | 2.172 | 2.201 | 2.029 | |
| Working Capital Turnover Ratio | -0.508 | -0.220 | -0.226 | -0.237 | -0.453 | |
| Operating Cash Flow Ratio | 0.000 | 0.104 | 0.111 | 0.114 | 0.128 | |
| Operating Cash Flow Sales Ratio | 0.457 | 0.506 | 0.486 | 0.558 | 0.596 | |
| Free Cash Flow Operating Cash Flow Ratio | -0.110 | -0.358 | 0.853 | -1.041 | -1.924 | |
| Debt Service Coverage Ratio | 2.170 | 0.138 | 0.181 | 0.155 | 0.160 | |
| Interest Coverage Ratio | 1.108 | 1.139 | 1.226 | 1.534 | 1.878 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.111 | 0.117 | 0.120 | 0.134 | |
| Operating Cash Flow Coverage Ratio | 0.111 | 0.107 | 0.110 | 0.109 | 0.119 | |
| Capital Expenditure Coverage Ratio | 0.901 | 0.736 | 6.813 | 0.490 | 0.342 | |
| Dividend Paid And Capex Coverage Ratio | 0.526 | 0.436 | 0.914 | 0.347 | 0.265 | |
| Dividend Payout Ratio | -9.960 | 9.904 | 3.146 | 3.356 | 3.310 | |
| Enterprise Value Multiple | 11.568 | 8.079 | 6.401 | 7.699 | 7.703 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 6.4% | ▼-72.5% | ▼-60.3% |
| Ebit Margin | 23.4% | ▼-2.2% | ▼-7.0% |
| Ebitda Margin | 60.1% | ▼-6.0% | ▼-10.7% |
| Operating Profit Margin | 30.7% | ▲7.0% | ▲2.4% |
| Pretax Profit Margin | -4.3% | ▼-9.1% | ▼-13.6% |
| Continuous Operations Profit Margin | -4.3% | ▼-9.1% | ▼-13.6% |
| Net Profit Margin | -3.6% | ▼-8.4% | ▼-12.6% |
| Bottom Line Profit Margin | -3.6% | ▼-4.2% | ▼-9.1% |
| Current Ratio | 0.000 | ▼-0.026 | ▼-0.028 |
| Quick Ratio | 0.000 | ▼-0.026 | ▼-0.028 |
| Solvency Ratio | 0.075 | ▼-0.015 | ▼-0.024 |
| Cash Ratio | 0.000 | ▼-0.010 | ▼-0.006 |
| Price To Earnings Ratio | -38.418 | ▼-151.192 | ▼-68.568 |
| Price To Earnings Growth Ratio | 0.098 | ▲1.290 | ▼-0.950 |
| Forward Price To Earnings Growth Ratio | 0.098 | ▲1.290 | ▼-0.950 |
| Price To Earnings Diluted Ratio | -38.418 | ▼-151.192 | ▼-62.798 |
| Price To Earnings Diluted Growth Ratio | 0.098 | ▲1.290 | ▲0.411 |
| Price To Book Ratio | 0.917 | ▲0.745 | ▲0.612 |
| Price To Sales Ratio | 2.905 | ▲2.239 | ▲1.780 |
| Price To Free Cash Flow Ratio | -57.895 | ▼-54.217 | ▼-45.536 |
| Price To Operating Cash Flow Ratio | 6.354 | ▲5.038 | ▲4.067 |
| Debt To Assets Ratio | 0.534 | ▲0.014 | ▲0.032 |
| Debt To Equity Ratio | 1.302 | ▲0.078 | ▲0.174 |
| Debt To Capital Ratio | 0.566 | ▲0.015 | ▲0.037 |
| Long Term Debt To Capital Ratio | 0.564 | ▲0.537 | ▲0.404 |
| Financial Leverage Ratio | 2.437 | ▲0.085 | ▲0.199 |
| Working Capital Turnover Ratio | -0.508 | ▼-0.288 | ▼-0.179 |
| Operating Cash Flow Ratio | 0.000 | ▼-0.104 | ▼-0.091 |
| Operating Cash Flow Sales Ratio | 0.457 | ▼-0.049 | ▼-0.063 |
| Free Cash Flow Operating Cash Flow Ratio | -0.110 | ▲0.248 | ▲0.406 |
| Debt Service Coverage Ratio | 2.170 | ▲2.032 | ▲1.609 |
| Interest Coverage Ratio | 1.108 | ▼-0.032 | ▼-0.269 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | ▼-0.111 | ▼-0.096 |
| Operating Cash Flow Coverage Ratio | 0.111 | ▲0.004 | ▼-0.000 |
| Capital Expenditure Coverage Ratio | 0.901 | ▲0.165 | ▼-0.955 |
| Dividend Paid And Capex Coverage Ratio | 0.526 | ▲0.091 | ▲0.029 |
| Dividend Payout Ratio | -9.960 | ▼-19.864 | ▼-11.911 |
| Enterprise Value Multiple | 11.568 | ▲3.489 | ▲3.278 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $467.7M | $92.2M | $91.7M | $91.5M | $84.8M | |
| Enterprise value | $1.12B | $739.0M | $714.6M | $792.2M | $657.4M | |
| EV / Sales | 6.95x | 5.34x | 5.07x | 5.78x | 5.68x | |
| EV / Op. cash flow | 15.20x | 10.55x | 10.44x | 10.35x | 9.53x | |
| EV / Free cash flow | -138.51x | -29.47x | 12.24x | -9.95x | -4.96x | |
| EV / EBITDA | 11.57x | 8.08x | 6.40x | 7.70x | 7.70x | |
| Net debt / EBITDA | 6.73x | 7.07x | 5.58x | 6.81x | 6.71x | |
| Current ratio | 0.00x | 0.03x | 0.02x | 0.05x | 0.05x | |
| Income quality | -12.61x | 10.56x | 3.32x | 3.83x | 3.76x | |
| Graham number | — | $107 | $198 | $199 | $205 | |
| Graham net-net | -$52 | -$261 | -$250 | -$280 | -$253 | |
| Tax burden | 84.8% | 99.1% | 94.8% | 95.7% | 96.1% | |
| Interest burden | -18.3% | 18.9% | 41.3% | 44.2% | 48.2% | |
| Working capital | $19.8M | -$654.1M | -$605.0M | -$640.0M | -$515.6M | |
| Invested capital | $87.7M | -$586.9M | -$522.1M | -$537.8M | -$418.0M | |
| Return on assets | -0.5% | 0.5% | 1.6% | 1.4% | 1.4% | |
| Operating ROA | 4.0% | 2.6% | 2.8% | 2.9% | 3.1% | |
| Return on tangible assets | -0.5% | 0.6% | 1.7% | 1.5% | 1.5% | |
| Return on equity | -1.1% | 1.2% | 3.5% | 3.0% | 2.8% | |
| Return on invested capital | 4.0% | 2.7% | 3.1% | 2.8% | 3.0% | |
| Return on capital employed | 4.0% | 5.6% | 5.8% | 5.4% | 5.1% | |
| Earnings yield | -1.2% | 7.2% | 22.5% | 20.9% | 20.8% | |
| Free cash flow yield | -1.7% | -27.2% | 63.7% | -87.0% | -156.5% | |
| Capex / Op. cash flow | 111.0% | 135.8% | 14.7% | 204.1% | 292.4% | |
| Capex / Depreciation | 138.4% | 169.6% | 17.0% | 270.9% | 426.3% | |
| Capex / Sales | 50.7% | 68.7% | 7.1% | 113.9% | 174.1% | |
| SG&A / Sales | 12.4% | 15.3% | 12.0% | 12.1% | 14.2% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.0% | 3.7% | 3.0% | 3.4% | 5.0% | |
| Intangibles / Total assets | 4.2% | 4.8% | 5.7% | 7.0% | 7.4% | |
| Days sales outstanding | 17d | 20d | 18d | 22d | 20d | |
| Days payables outstanding | 0d | 205d | 166d | 200d | 244d | |
| Operating cycle | 17d | 20d | 18d | 22d | 20d | |
| Cash conversion cycle | 17d | -185d | -148d | -178d | -224d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+407.3%EV / Sales ▲+30.2%EV / EBITDA ▲+43.2%EV / Op. cash flow ▲+4.652Earnings yield ▼-0.084
Profitability
Return on equity ▼-0.024Return on assets ▼-0.010Return on invested capital ▲+0.013Return on capital employed ▼-0.016Operating ROA ▲+0.014Income quality ▼-23.173Tax burden ▼-0.143
Efficiency
Days sales outstanding ▼-3.546Days payables outstanding ▼-205.491Operating cycle ▼-3.546Cash conversion cycle ▲+201.945Capex / Sales ▼-0.180R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.026Net debt / EBITDA ▼-0.338Working capital ▲+673935000.000Invested capital ▲+674557000.000Intangibles / Total assets ▼-0.006
Change over 5 years
Valuation
Market cap ▲+451.6%EV / Sales ▲+22.4%EV / EBITDA ▲+50.2%EV / Op. cash flow ▲+5.669Earnings yield ▼-0.220
Profitability
Return on equity ▼-0.040Return on assets ▼-0.019Return on invested capital ▲+0.010Return on capital employed ▼-0.011Operating ROA ▲+0.008Income quality ▼-16.373Tax burden ▼-0.113
Efficiency
Days sales outstanding ▼-2.902Days payables outstanding ▼-243.773Operating cycle ▼-2.902Cash conversion cycle ▲+240.872Capex / Sales ▼-1.234R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.046Net debt / EBITDA ▲+0.023Working capital ▲+535462000.000Invested capital ▲+505683000.000Intangibles / Total assets ▼-0.032
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-11 Global Medical REIT Q2 Earnings Call Highlights Chiron Real Estate reported second-quarter results as it continues to reposition its portfolio toward senior housing and away from outpatient medical real estate, with management emphasizing capital recycling, leadership additions and a growing investment pipeline. Chief Executive Officer Mark Decker Jr. said the company''s existing portfolio remained operationally stable while it pursued a broader strategic
- 2026-08-06 Chiron Real Estate Inc. (XRN) Q2 2026 Earnings Call Transcript Chiron Real Estate Inc. (XRN) Q2 2026 Earnings Call Transcript
- 2026-08-05 Chiron Real Estate Inc. Announces Second Quarter 2026 Financial Results BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced financial results for the three months ended June 30, 2026 and other data. Mark Decker, Jr., Chief Executive Officer and President stated, "When we outlined our priorities earlier this year, we committed to active capital allocation, portfolio repositioning, and building the capabilities necessary to support our next phase of growth. During the second quarter, we made meaningful prog.
- 2026-08-04 Global Medical REIT (NYSE:XRN) versus NorthWest Healthcare Properties Real Estate Investment Trust (OTCMKTS:NWHUF) Financial Comparison NorthWest Healthcare Properties Real Estate Investment Trust (OTCMKTS:NWHUF - Get Free Report) and Global Medical REIT (NYSE: XRN - Get Free Report) are both real estate companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Valuation
- 2026-08-03 Chiron Real Estate Inc. Announces Employee Inducement Awards Under NYSE Rule 303A.08 BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced that it issued inducement awards to three new executive officers. Effective August 3, 2026, in connection with commencing employment with Chiron, and as a material inducement to their acceptance of employment with the Company, Aaron Roseth, Chief Operating Officer, Robert H. Zeiller, Chief Development Officer and Head of Seniors Housing, and Matthew Whitlock, Chief Investment Officer.
- 2026-08-03 Chiron Real Estate Inc. Appoints Matthew Whitlock as Chief Investment Officer BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced the appointment of Matthew Whitlock as Chief Investment Officer, effective August 3, 2026. Mr. Whitlock will lead the Company''s investment activities, with responsibility for sourcing, structuring, and executing senior housing investments, cultivating strategic partnerships, and helping guide the continued growth of Chiron''s senior housing platform. “We are excited to welcome Matthew.
- 2026-07-27 Chiron Real Estate: A High-Yield REIT Idea Amid Shift To Senior-Care Chiron Real Estate is rated a buy, driven by macro tailwinds, a strategic pivot toward senior-care assets, and resilient market confidence. XRN benefits from strong demographic demand, limited new senior housing supply, and Sunbelt penetration, positioning it for durable growth. Despite recent FFO and EBITDA margin declines, XRN offers a 5%+ yield with 2.3x dividend coverage and monthly payouts, supporting income-focused investors.
- 2026-07-16 Chiron Real Estate Inc. Announces Dates for 2026 Second Quarter Earnings Release and Webcast BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), announced today that it intends to release its second quarter 2026 financial results after the market closes on Wednesday, August 5, 2026. The Company intends to hold a conference call to discuss those results the following day, Thursday, August 6, 2026, at 9:00 a.m. Eastern Time. Webcast Information Participants may access the call via live webcast by visiting the “Investor Relations” section of th.
- 2026-07-14 Chiron Real Estate Inc. Strengthens Executive Leadership Team With Key Appointments BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced the appointments of Robert “Bobby” Zeiller as Chief Development Officer and Head of Seniors Housing and Aaron Roseth as Chief Operating Officer, effective July 16, 2026. In connection with these appointments, Danica Holley, the Company''s current Chief Operating Officer, has been appointed Chief Administrative Officer. The appointments further strengthen Chiron''s leadership team as th.
- 2026-06-30 Chiron Real Estate Inc. Accelerates Portfolio Transition via Recapitalization of IRF Assets BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), announced today that it has completed a sale of seven inpatient rehabilitation facilities (“IRFs”) to a joint venture (the “JV”) between the Company and a U.S. public pension fund advised by a global real estate investment management firm. The initial portfolio of IRFs was valued at an aggregate $217 million. The transaction was structured through a JV in which an investor acquired an 85% equity int.